Potential modifications to the risk-adjustment model used for the Affordable Care Act commercial plans could improve the model and appropriately compensate plans that enroll sicker enrollees.
Potential modifications to the risk-adjustment model used for the Affordable Care Act (ACA) commercial plans could improve the model and appropriately compensate plans that enroll sicker enrollees, according to a new report from Avalere Health. This change would encourage plans to compete based on cost, quality, and health management.
The report, “Evolving the Risk-Adjustment Model to Improve Payment Accuracy in the Individual & Small Group Market,” examines the risk-adjustment program used for the ACA in the commercial market, provides an analysis of the limitations facing the current model, and suggests potential modifications that could improve it.
The ACA created a risk-adjustment program to promote accuracy for health plans by appropriately compensating plans for the financial costs of their enrollees, the report explains. The risk adjustment allows the plans to receive a higher payment for sicker enrollees with costlier care and a lower payment for healthier enrollees, whose care costs less. The goal of the risk-adjustment program is to encourage insurers to compete based on the efficiency and value of their plans, as opposed to attracting healthier enrollees.
“If the risk-adjustment model is inaccurate, then plans that enroll a disproportionate share of sicker enrollees may experience financial losses and exit the market, even if they have priced premiums accurately,” said Tom Kornfield, vice president of Avalere. “By appropriately compensating plans, an accurate model encourages plans to compete based on cost, quality, and health management.”
Limitations to Existing ACA Risk-Adjustment Model
The report identifies 3 main limitations of the existing risk-adjustment model for the individual and small-group market:
The Avalere report concludes that the unique characteristics of the exchange and individual market populations are not being adequately accounted for in the existing risk-adjustment model, so changes should be made to the model to ensure that health plans have an incentive to remain participants in the exchange market.
Methotrexate May Lower Blood Pressure in Rheumatoid Arthritis
September 4th 2025Methotrexate significantly lowered systolic blood pressure compared with sulfasalazine in adults with newly diagnosed rheumatoid arthritis, suggesting potential cardiovascular benefits beyond its anti-inflammatory effects.
Read More
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen